1-3 of 3
Rajesh Soni
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Inhibitor of DNA binding 2 (ID2) is epigenetically regulated during lymphomagenesis and constitutes a novel therapeutic target in mature T-cell lymphoma

Free
Anouchka Laurent, Hannah I. Miller, Ryan D. Najac, Robert Albero, Jose R. Cortes, Cindy Ma, Wen-Hsuan Wendy Lin, Anqi Wang, Ruth Alonso Alonso, Laura Quevedo, Rajesh Soni, Ouathek Ouerfelli, Raul Rabadan, Robert Benezra, Teresa Palomero
Journal: Blood
Blood (2025) 146 (Supplement 1): 54.
https://doi.org/10.1182/blood-2025-54
Published: 2025
Journal Articles

A Novel Bi-Specific T-Cell Engager Targeting ILT3 Is Potently Effective in Multiple Myeloma

Free
Francesco Di Meo, Anjushree Iyer, Keith Akama, Christina Yu, Rujin Cheng, Annamaria Cesarano, Silvia Marino, Arafat Aljoufi, Rajesh Soni, Julie M Roda, James Sissons, Ly P Vu, Monica L. Guzman, Kun Huang, David G. Roodman, Fabiana Perna
Journal: Blood
Blood (2022) 140 (Supplement 1): 671–672.
https://doi.org/10.1182/blood-2022-167584
Published: 2022
Journal Articles

Probing the AML Surfaceome for Chimeric Antigen Receptor (CAR) Targets

Free
Fabiana Perna, MDPhD, Samuel Berman, Jorge Mansilla-Soto, PhD, Mohamad Hamieh, PhD, Rupa Juthani, MD, Rajesh Soni, PhD, Justin Eyquem, PhD, Ronald Hendrickson, PhD, Cameron Brennan, MD, Michel Sadelain, MD PhD
Journal: Blood
Blood (2016) 128 (22): 526.
https://doi.org/10.1182/blood.V128.22.526.526
Published: 2016